All Episodes

December 31, 2021 28 mins

Tripawd Talk Radio Episode #106: On this show we speak with Dr Rachel Venable about how pet cancer care consulting makes treatment more accessible than ever, for everyone. Dr. Venable is a Board Certified medical oncologist who obtained her veterinary degree from the University of Missouri. She completed her residency at the renowned CSU Flint Animal Cancer Center.

And, she's founded the Pet Cancer Care Consulting service as a way to help pet owners who want to consult with a veterinary oncologist but cannot access one in their area. This means that anyone can consult with a board certified oncologist and their vet to discuss the best treatment plan for their pets with cancer, wherever they are.

Coping with your pet's cancer is challenging enough. With only about 450 boarded veterinary oncologists in the US and Canada, what do you do without access to vet oncology services near you? Learn all about remote Pet Cancer Care Consulting with Dr. Rachel Venable on this episode of Tripawd Talk Radio...

Resources mentioned in this episode:

Pet Cancer Care Consulting
https://petcancercareconsulting.com/

Podcast: Torigen Immunotherapy Vaccine: Hope for Pets with Cancer
https://tripawds.com/2021/07/07/torigen-immunotherapy-vaccine/


Tripawds News: Veterinary Oncology
https://tripawds.com/tag/oncology/

Tripawds News: Pet Cancer Immunotherapy (Vaccines)
https://tripawds.com/tag/immunotherapy/


Watch Episode Video:
https://youtu.be/NHFDcj-qrEA

Find All Tripawd Talk Radio Episodes & Subscribe:
https://tripawds.com/radio

Support the show

Mark as Played

Advertise With Us

Popular Podcasts

1. Stuff You Should Know
2. Dateline NBC

2. Dateline NBC

Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

3. Crime Junkie

3. Crime Junkie

If you can never get enough true crime... Congratulations, you’ve found your people.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.